We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The correlations of serum Aβ1-42, P-Tau181, and Hcy levels with sleep disorders in Parkinson's disease patients.
- Authors
LI Yanyun; CHEN Xueping; TIAN Peipei; BAI Ting; GUO Qin; GUO Miao
- Abstract
Objective To investigate the correlations of serum Aβ1-42, P-Tau181, and Hcy levels with sleep disorders in patients with Parkinson's disease (PD). Methods A total of 80 PD patients were divided into a normal sleep group (< 7 points) and a sleep disorder group (≥ 7 points) based on the evaluations with Pittsburgh Sleep Quality Index (PSQI). Univariate and multivariate logistic regression analyses were performed to investigate the correlations between the levels of serum Aβ1-42, P-Tau181, and Hcy levels and sleep disorders. Receiver operating characteristic (ROC) curves were used to analyze the efficacy parameters of different indicators in predicting sleep disorders in those patients. Results Univariate and multivariate logistic regression analyses showed that serum Aβ1-42 and Hcy were protective and independent risk factors for sleep disorders in the PD patients, respectively (P < 0.05). The predictive AUCs of serum Aβ1-42 and Hcy levels for sleep disorders in the PD patients were 0.757 (95% CI: 0.652 ~ 0.861) and 0.796 (95% CI: 0.688 ~ 0.905), respectively. Conclusion The levels of serum Aβ1-42 and Hcy in PD patients are closely related to sleep disorders. Therefore, they can be used as predictive factors for clinical diagnosis of PD with sleep disorders.
- Publication
Journal of Practical Medicine / Shiyong Yixue Zazhi, 2024, Vol 40, Issue 11, p1483
- ISSN
1006-5725
- Publication type
Article
- DOI
10.3969/j.issn.1006-5725.2024.11.003